Kybella is a fat-destroying product that uses synthetic deoxycholic acid to destroy fat cells, resulting in a noticeable reduction in submental fullness or fullness under the chin. Deoxycholic acid occurs naturally in our bodies and aids in the breakdown and absorption of dietary fats. When injected into fat beneath the skin, fat cells are destroyed and absorbed leaving the treatment area with visible reduction of fullness. Once these fat cells are destroyed, they are also no longer able to store and accumulate fat. Patient’s may require up to six separate treatment, but once the aesthetic goal is achieved, no further treatments should be expected.
People that may be candidates for Kybella are those that are bothered, unhappy, self-conscious, or embarrassed by fat under the chin or submental fullness. Submental fullness makes you look older or heavier than you are or does not go away with exercise, weight loss, and a healthy diet. Kybella is also for those that do not want surgery.
A thorough examination will be performed to determine if you are a good candidate for Kybella. After the examination is performed and a treatment plan will be discussed. Treatment plans will likely include three to six sessions that are spaced one month apart.
Three weeks prior to any treatment session, all blood thinning medications and supplements should be discontinued to reduce the risk o bleeding and bruising. During this time those that smoke should also refrain from smoking as well as two weeks post treatment. During each session, the skin will be cleansed and prepared for the treatment. Multiple small injections are then delivered under the skin in the designated treatment area. The treatment process takes about 15-20 minutes. Repeat sessions are conducted one month apart until desired results are achieved.
After your treatment, you may resume normal activities immediately. You may experience some swelling, bruising, or numbness in the treatment area. Swelling and bruising may last for two to three weeks. Numbness may last up to six months.
In clinical studies, most patients reported moderate side effects, though severe risks are possible. The most common side effects are bruising, swelling, pain, redness, and numbness at the treatment site. Additionally, patients complained of induration, or a hard spot, at the injection site. Typically, these complaints resolve within three days. Dysphagia, or difficulty swallowing, occurred in 2 percent of clinical trial patients. Additionally, 4 percent experienced mandibular nerve injury. All occurrences of both conditions resolved spontaneously.